PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
| dc.contributor.author | Ozguroglu, Mustafa | |
| dc.contributor.author | De Bono, Johann S. | |
| dc.contributor.author | Fizazi, Karim | |
| dc.contributor.author | Saad, Fred | |
| dc.contributor.author | Shore, Neal D. | |
| dc.contributor.author | Roubaud, Guilhem | |
| dc.contributor.author | Penel, Nicolas | |
| dc.contributor.author | Matsubara, Nobuaki | |
| dc.contributor.author | Mehra, Niven | |
| dc.contributor.author | Procopio, Giuseppe | |
| dc.contributor.author | Kolinsky, Michael Paul | |
| dc.contributor.author | Nishimura, Kazuo | |
| dc.contributor.author | Feyerabend, Susan | |
| dc.contributor.author | Joung, Jae Young | |
| dc.contributor.author | Vogelzang, Nicholas J. | |
| dc.contributor.author | Carducci, Michael Anthony | |
| dc.contributor.author | Kang, Jinyu | |
| dc.contributor.author | Poehlein, Christian Heinrich | |
| dc.contributor.author | Wu, Wenting | |
| dc.contributor.author | Hussain, Maha H. A. | |
| dc.date.accessioned | 2021-03-04T12:44:25Z | |
| dc.date.available | 2021-03-04T12:44:25Z | |
| dc.identifier.citation | De Bono J. S. , Fizazi K., Saad F., Shore N. D. , Roubaud G., Ozguroglu M., Penel N., Matsubara N., Mehra N., Procopio G., et al., "PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations", Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_78d8cb17-16d4-4205-95eb-45bd5814ed65 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/82852 | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Onkoloji | |
| dc.title | PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 38 | |
| dc.contributor.firstauthorID | 2277886 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]